BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 30614883)

  • 1. Elevated liver enzymes and cardiovascular mortality: a systematic review and dose-response meta-analysis of more than one million participants.
    Rahmani J; Miri A; Namjoo I; Zamaninour N; Maljaei MB; Zhou K; Cerneviciute R; Mousavi SM; Varkaneh HK; Salehisahlabadi A; Zhang Y
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):555-562. PubMed ID: 30614883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies.
    Kunutsor SK; Apekey TA; Khan H
    Atherosclerosis; 2014 Sep; 236(1):7-17. PubMed ID: 24998934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Liver Enzymes and Mortality in Older Individuals: A Prospective Cohort Study.
    Mahady SE; Wong G; Turner RM; Mitchell P; Macaskill P; Craig JC; George J
    J Clin Gastroenterol; 2017; 51(5):439-445. PubMed ID: 27479143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum liver enzymes are associated with all-cause mortality in an elderly population.
    Koehler EM; Sanna D; Hansen BE; van Rooij FJ; Heeringa J; Hofman A; Tiemeier H; Stricker BH; Schouten JN; Janssen HL
    Liver Int; 2014 Feb; 34(2):296-304. PubMed ID: 24219360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of plasma levels of liver enzymes and risk of gestational diabetes mellitus: a systematic review and dose-response meta-analysis of observational studies.
    Zhao W; Zhang L; Zhang G; Varkaneh HK; Rahmani J; Clark C; Ryan PM; Abdulazeem HM; Salehisahlabadi A
    Acta Diabetol; 2020 Jun; 57(6):635-644. PubMed ID: 31781958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity.
    Robles-Diaz M; Garcia-Cortes M; Medina-Caliz I; Gonzalez-Jimenez A; Gonzalez-Grande R; Navarro JM; Castiella A; Zapata EM; Romero-Gomez M; Blanco S; Soriano G; Hidalgo R; Ortega-Torres M; Clavijo E; Bermudez-Ruiz PM; Lucena MI; Andrade RJ; ;
    Liver Int; 2015 Nov; 35(11):2474-82. PubMed ID: 25809419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality.
    Arndt V; Brenner H; Rothenbacher D; Zschenderlein B; Fraisse E; Fliedner TM
    Int Arch Occup Environ Health; 1998 Sep; 71(6):405-12. PubMed ID: 9766914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of serum liver enzyme levels and their changes over time with all-cause and cause-specific mortality in the general population: a large-scale national health screening cohort study.
    Kim KN; Joo J; Sung HK; Kim CH; Kim H; Kwon YJ
    BMJ Open; 2019 Jun; 9(5):e026965. PubMed ID: 31154308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.
    Ruhl CE; Everhart JE
    Gastroenterology; 2009 Feb; 136(2):477-85.e11. PubMed ID: 19100265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver enzymes and risk of all-cause mortality in general populations: a systematic review and meta-analysis.
    Kunutsor SK; Apekey TA; Seddoh D; Walley J
    Int J Epidemiol; 2014 Feb; 43(1):187-201. PubMed ID: 24585856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.
    Unalp-Arida A; Ruhl CE
    Hepatology; 2016 Apr; 63(4):1170-83. PubMed ID: 26663021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of gamma-glutamyl transferase and alkaline phosphatase as prognostic markers in patients with coronary heart disease.
    Ndrepepa G; Holdenrieder S; Cassese S; Fusaro M; Xhepa E; Laugwitz KL; Schunkert H; Kastrati A
    Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):64-70. PubMed ID: 29126670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating alanine transaminase (ALT) and γ-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus Metabolism Study.
    Liu X; Hamnvik OP; Chamberland JP; Petrou M; Gong H; Christophi CA; Christiani DC; Kales SN; Mantzoros CS
    Metabolism; 2014 Jun; 63(6):773-82. PubMed ID: 24726813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of data on biological variation for alanine aminotransferase, aspartate aminotransferase and γ-glutamyl transferase.
    Carobene A; Braga F; Roraas T; Sandberg S; Bartlett WA
    Clin Chem Lab Med; 2013 Oct; 51(10):1997-2007. PubMed ID: 24072574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.
    Hann HW; Wan S; Myers RE; Hann RS; Xing J; Chen B; Yang H
    PLoS One; 2012; 7(10):e47687. PubMed ID: 23112834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma.
    Huang H; Wang XP; Li XH; Chen H; Zheng X; Lin JH; Kang T; Zhang L; Chen PS
    BMC Cancer; 2017 Aug; 17(1):544. PubMed ID: 28806937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of serum AST, ALT, AP and GGT activities in the diagnosis of liver diseases in dogs].
    Kraft W; Ghermai AK; Winzinger H; Knoll L
    Berl Munch Tierarztl Wochenschr; 1983 Dec; 96(12):421-31. PubMed ID: 6141785
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased liver markers are associated with higher risk of type 2 diabetes.
    Ko SH; Baeg MK; Han KD; Ko SH; Ahn YB
    World J Gastroenterol; 2015 Jun; 21(24):7478-87. PubMed ID: 26139993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Gao M; Cheng Y; Zheng Y; Zhang W; Wang L; Qin L
    BMC Cardiovasc Disord; 2017 Jan; 17(1):43. PubMed ID: 28129742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver function tests: what is the risk?
    Titcomb CP
    J Insur Med; 2003; 35(1):26-35. PubMed ID: 14694823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.